Skip to main content


Fig. 1 | Clinical Epigenetics

Fig. 1

From: Efficacy of EZH2 inhibitory drugs in human papillomavirus-positive and human papillomavirus-negative oropharyngeal squamous cell carcinomas

Fig. 1

Drug effects on H3K27me3 levels vary between cell line’s HPV status. Western Blot analysis of H3K27me3 following 7-day treatments with GSK-343, DZNeP, or EPZ-5687 in a SCC47, b SCC104, c SCC1, d SCC9. Left: Western Blots with Coomassie blue staining (shown below Western blot) utilized as loading control. Right: Quantification of Western blot to left of graph based on fold differences to DMSO-treated cells

Back to article page